PRODUCTS
SERVICES
The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies
1.80
21 yrs 1 m
1%
8,569.15 Crs
1% on or before 1M, Nil after 1M
Large Growth
9.09
SIP 100 & Lumpsum 5000
NA
Sailesh Raj Bhan
Investors understand that their principal will be at very high risk